Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2020

Jun 8, 2020

31708_dirs_2020-06-08_262499bd-ded9-4b69-a310-362bb64b9623.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2020-06-04

Reporting Person: Pellegrino Joseph P JR (Director, Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-04 Dividend Equivalent Rights $ A 6 Acquired Common Stock (6) Direct
2020-06-04 Dividend Equivalent Rights $ A 4 Acquired Common Stock (4) Direct
2020-06-04 Dividend Equivalent Rights $ A 7 Acquired Common Stock (7) Direct
2020-06-04 Dividend Equivalent Rights $ A 6 Acquired Common Stock (6) Direct

Footnotes

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.